Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,886 | -24,204 | -19,314 | -12,032 | -5,772 |
| Depreciation Amortization | 20 | 73 | 55 | 37 | 17 |
| Accounts receivable | -11 | 32 | 46 | 30 | 17 |
| Other Working Capital | 87 | -525 | -75 | 376 | -106 |
| Other Operating Activity | 2,310 | 7,551 | 5,764 | 3,128 | 861 |
| Operating Cash Flow | $-5,480 | $-17,073 | $-13,523 | $-8,462 | $-4,982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -18 | -16 | -13 | -8 |
| Investing Cash Flow | $-35 | $-18 | $-16 | $-13 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,824 | 11,503 | 25 | 25 | N/A |
| Other Financing Activity | -911 | -381 | -30 | -20 | -10 |
| Financing Cash Flow | $9,913 | $11,122 | $-5 | $5 | $-10 |
| Exchange Rate Effect | 162 | -590 | -218 | -484 | -75 |
| Beginning Cash Position | 15,611 | 21,886 | 22,198 | 22,109 | 21,296 |
| End Cash Position | 20,171 | 15,328 | 8,437 | 13,155 | 16,221 |
| Net Cash Flow | $4,560 | $-6,558 | $-13,761 | $-8,954 | $-5,075 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,480 | -17,073 | -13,523 | -8,462 | -4,982 |
| Capital Expenditure | -35 | -18 | -16 | -13 | -8 |
| Free Cash Flow | -5,514 | -17,090 | -13,539 | -8,476 | -4,990 |